India’s 5G fantasy: The future looks decidedly dim

The country is dithering over starting field trials while dreaming of securing patents in this revolutionary technology

WIPO’s piracy blacklist is flawed

Why is the UN body putting a stamp of approval on a system that is patently unjust and dangerous

CRISPR: A cutting-edge battle

The US has reopened the battle over CRISPR that has already seen several twists and turns in the past seven years

Why the US fears China

The trade war launched by Trump has the alleged theft of intellectual property at its core 

कम नहीं हुआ है बीज के अधिकार पर मंडराता खतरा

अमेरिकी कंपनी पेप्सिको और गुजरात के आलू उत्पादकों के बी…

Who cares about high drug prices?

Drug manufacturers have started charging high prices at levels unheard of earlier, but nobody is bothered

The new Patanjali of yoga

Did anyone think that Maharishi Patanjali, the giver of those priceless exercises, would become private property one day?

A strike for affordable medicines

Recently, the Delhi High Court allowed makers of generic medicines in India to export patented drugs to importing countries for regulatory approval

Tricky issue of policing the Internet

Instead of bans, regulations may be a better way of dealing with the downside of digital technology 

Farmers' rights are a hot potato

The fallout between US major PepsiCo and Gujarat’s potato growers underlines the looming threat to farmers’ rights in India over …

New ruse in Big Pharma's old game

Drug multinationals are lobbying for a devious patent linkage system to block the entry of competitive generics

Monsanto's troublesome trait

Bayer is battling seed companies and farmers in several countries over royalty on Monsanto's GM seeds

US sound and fury over drug prices

The US Senate is outraged by the rapacious pricing policy of drug firms but will it act to reform the system?

Bedaquiline and India's patent law

Opposition to the new patent claims on the Johnson & Johnson drug is a test of how well the rules against evergreening are working

Software outsmarts drug research

Now, a programme can bypass patented drug pathways and create synthetically-produced medicines

No worries? Ask Simba

A furore over Disney's trademark on the Swahili phrase Hakuna Matata heats up the cultural appropriation debate

Patent Prosecution Highway: The fast track to disaster

India's decision to start one for Japanese firms could open the tollgates to hasty approvals

Pressed for sharing

The Uttarakhand high court order on Ramdev's firm to pay for use of bioresources has put herbal companies on notice

When judges copy

Should the rules on plagiarism matter as much as the independent analysis made by judges in adjudicating cases?

You can be sued for your social media posts

Copyright issues related to social media posts are a concern as platforms are shutting down accounts without notice

Beware of Japan's trade ambitions

Japan is pushing for higher levels of intellectual property protection that will cut access to affordable medicines

This is how rich nations protect profits of multinational pharma firms

When rich nations insist on patent linkage provisions in bilateral and regional trade pacts, there is a way out

The zero budget farming discord

There is unease over the crusader of natural farming, Subhash Palekar, for renaming the technique after himself

Can activism check Big Pharma’s profit motives?

As prices of life-saving drugs skyrocket, people from diverse fields are getting together to fight Big Pharma

US trading on thin ice

As Trump escalates the trade war with China, the key question is what constitutes theft of intellectual property